Global Anesthesia Drugs Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 – 2025
Anesthesia refers to suppressing pain arising during surgeries. Two main types of anesthesia are practices namely, general and local. General anesthesia lead to loss of consciousness which is reversible. Local anesthesia leads to loss of sensation of a particular part of the body, while maintaining the consciousness.
Commonly used drugs for inducing local anaesthesia include, Lidocaine, Ropivacaine, Bupivacaine, Prilocaine, procaine, prilocaine, amethocaine, levobupivacaine, mepivacaine, dibucaine and Chloro-procaine among others. Commonly used drugs for inducing general anesthesia include but are not limited to Halothane, Desflurane, Enflurane, Methoxyflurane, Isoflurane, Sevoflurane, and Nitrous oxide. Xenon is rarely used. In addition, drugs of class barbiturates namely, Amobarbital, Thiamylal, Methohexital, and Thiopental are also used. Furthermore, benzodiazepines like Diazepam, Midazolam and Lorazepam along with propofol, ketamine and etomidate are also used. These agents are administered intravenously.
Rise in number of surgeries is the prime factor for the growth of the anesthesia drugs market. In addition, rising dental procedures where local anesthesia is used are fueling the market growth. On the other hand, adverse effects are the key restraining factors of the market. In addition, these drugs come under highly regulated products which results in manufacturing and sale of these products relatively costly. Moreover, requirement of highly skilled doctors is further hindering the market growth.
The various contributors involved in the value chain of Anesthesia Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Anesthesia Drugs include
Claris Life sciences
Market Size Split by Type
Market Size Split by Application
Market size split by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Anesthesia Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Anesthesia Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anesthesia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anesthesia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anesthesia Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anesthesia Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anesthesia Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.